J.P. Morgan Life Sciences Private Capital Hires Joseph Siletto to Target Investments in Healthcare Transformation

Key Announcement - Joseph Siletto joins J P Morgan Private Capital as Co Managing Partner alongside Anya Schiess and Gaurav Gupta reporting to Stephen Squinto [1] - The expanded team will focus on investing in Series B through pre IPO stage healthcare companies specifically in biotechnology medical devices health technology and services and diagnostics and tools subsectors [1] Joseph Siletto's Background - Joseph Siletto has over 25 years of experience in private healthcare investments most recently as Managing Director at Vivo Capital [2] - He co founded Scion Medical Technologies which was sold to NYSE listed Varian Medical and is now part of Siemens [4] - Prior to Vivo Capital he was an investment banker at Cowen & Company and Banc of America Securities focusing on healthcare M&A and capital raising [4] Strategic Focus of J P Morgan Life Sciences Private Capital - The platform aims to finance opportunities that enhance disease treatment and patient outcomes while reducing costs through innovative treatment methods cutting edge technology AI driven treatments improved diagnostic tools and cost effective healthcare solutions [3] - The team believes advancements in biotechnology and AI will transform the healthcare industry and position them as a preferred partner for innovative companies [3] About J P Morgan Private Capital - J P Morgan Private Capital provides customized financing solutions for private companies with a focus on venture and growth investing across consumer technology and life sciences sectors [5] - It is part of J P Morgan Global Alternatives which manages $214 billion in assets as of March 31 2024 and covers a wide range of alternative investment strategies [6] About J P Morgan Asset Management - J P Morgan Asset Management manages$3 2 trillion in assets as of March 31 2024 serving institutions retail investors and high net worth individuals globally [7] - It offers investment management in equities fixed income real estate hedge funds private equity and liquidity [7] About JPMorgan Chase & Co - JPMorgan Chase & Co is a leading financial services firm with $4 1 trillion in assets and$337 billion in stockholders equity as of March 31 2024 [8] - The firm operates globally in investment banking financial services for consumers and small businesses commercial banking financial transaction processing and asset management [8]